Size-Dependent Bioactivity of Silver Nanoparticles: Antibacterial Properties, Influence on Copper Status in Mice, and Whole-Body Turnover

Ekaterina A Skomorokhova,1,2 Tatiana P Sankova,3 Iurii A Orlov,1 Andrew N Savelev,3 Daria N Magazenkova,3 Mikhail G Pliss,4,5 Alexey N Skvortsov,3 Ilya M Sosnin,1 Demid A Kirilenko,1,6 Ivan V Grishchuk,3 Elena I Sakhenberg,7 Elena V Polishchuk,1,8 Pavel N Brunkov,1,6 Alexey E Romanov,1,6 Ludmila V P...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Skomorokhova EA, Sankova TP, Orlov IA, Savelev AN, Magazenkova DN, Pliss MG, Skvortsov AN, Sosnin IM, Kirilenko DA, Grishchuk IV, Sakhenberg EI, Polishchuk EV, Brunkov PN, Romanov AE, Puchkova LV, Ilyechova EY
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/aad57b2a7574403f9eeaaef2335bf8f5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:aad57b2a7574403f9eeaaef2335bf8f5
record_format dspace
institution DOAJ
collection DOAJ
language EN
topic silver nanoparticles
copper status
ceruloplasmin
alpha-2-macroglobulin
bile
urine
Medical technology
R855-855.5
Chemical technology
TP1-1185
spellingShingle silver nanoparticles
copper status
ceruloplasmin
alpha-2-macroglobulin
bile
urine
Medical technology
R855-855.5
Chemical technology
TP1-1185
Skomorokhova EA
Sankova TP
Orlov IA
Savelev AN
Magazenkova DN
Pliss MG
Skvortsov AN
Sosnin IM
Kirilenko DA
Grishchuk IV
Sakhenberg EI
Polishchuk EV
Brunkov PN
Romanov AE
Puchkova LV
Ilyechova EY
Size-Dependent Bioactivity of Silver Nanoparticles: Antibacterial Properties, Influence on Copper Status in Mice, and Whole-Body Turnover
description Ekaterina A Skomorokhova,1,2 Tatiana P Sankova,3 Iurii A Orlov,1 Andrew N Savelev,3 Daria N Magazenkova,3 Mikhail G Pliss,4,5 Alexey N Skvortsov,3 Ilya M Sosnin,1 Demid A Kirilenko,1,6 Ivan V Grishchuk,3 Elena I Sakhenberg,7 Elena V Polishchuk,1,8 Pavel N Brunkov,1,6 Alexey E Romanov,1,6 Ludmila V Puchkova,1– 3 Ekaterina Yu Ilyechova1,2 1International Research Center of Functional Materials and Devices of Optoelectronics, ITMO University, St. Petersburg, Russia; 2Department of Molecular Genetics, Research Institute of Experimental Medicine, St. Petersburg, Russia; 3Higher Engineering Physics School of the Institute of Physics, Nanotechnology and Telecommunications, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia; 4Department of Experimental Physiology and Pharmacology, Almazov National Medical Research Centre, St. Petersburg, Russia; 5Laboratory of Blood Circulation Biophysics, Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia; 6Center of Nanoheterostructures Physics, Ioffe Institute, Russian Academy of Sciences, St. Petersburg, Russia; 7Laboratory of Cell Protection Mechanisms, Institute of Cytology, Russian Academy of Sciences, St. Petersburg, Russia; 8Telethon Institute of Genetics and Medicine, Pozzuoli, Naples, ItalyCorrespondence: Ekaterina Yu Ilyechova Department of Molecular GeneticsResearch Institute of Experimental Medicine, Acad. Pavlov Street, 12, St. Petersburg 197376, RussiaTel +79217605274Fax +78122322307Email ilichevaey@itmo.ruPurpose: The ability of silver nanoparticles (AgNPs) of different sizes to influence copper metabolism in mice is assessed.Materials and Methods: AgNPs with diameters of 10, 20, and 75 nm were fabricated through a chemical reduction of silver nitrate and characterized by UV/Vis spectrometry, transmission and scanning electronic microscopy, and laser diffractometry. To test their bioactivity, Escherichia coli cells, cultured A549 cells, and C57Bl/6 mice were used. The antibacterial activity of AgNPs was determined by inhibition of colony-forming ability, and cytotoxicity was tested using the MTT test (viability, %). Ceruloplasmin (Cp, the major mammalian extracellular copper-containing protein) concentration and enzymatic activity were measured using gel-assay analyses and WB, respectively. In vitro binding of AgNPs with serum proteins was monitored with UV/Vis spectroscopy. Metal concentrations were measured using atomic absorption spectrometry.Results: The smallest AgNPs displayed the largest dose- and time-dependent antibacterial activity. All nanoparticles inhibited the metabolic activity of A549 cells in accordance with dose and time, but no correlation between cytotoxicity and nanoparticle size was found. Nanosilver was not uniformly distributed through the body of mice intraperitoneally treated with low AgNP concentrations. It was predominantly accumulated in liver. There, nanosilver was included in ceruloplasmin, and Ag-ceruloplasmin with low oxidase activity level was formed. Larger nanoparticles more effectively interfered with the copper metabolism of mice. Large AgNPs quickly induced a drop of blood serum oxidase activity to practically zero, but after cancellation of AgNP treatment, the activity was rapidly restored. A major fraction of the nanosilver was excreted in the bile with Cp. Nanosilver was bound by alpha-2-macroglobulin in vitro and in vivo, but silver did not substitute for the copper atoms of Cp in vitro.Conclusion: The data showed that even at low concentrations, AgNPs influence murine copper metabolism in size-dependent manner. This property negatively correlated with the antibacterial activity of AgNPs.Keywords: silver nanoparticles, copper status, ceruloplasmin, alpha-2-macroglobulin, bile, urine
format article
author Skomorokhova EA
Sankova TP
Orlov IA
Savelev AN
Magazenkova DN
Pliss MG
Skvortsov AN
Sosnin IM
Kirilenko DA
Grishchuk IV
Sakhenberg EI
Polishchuk EV
Brunkov PN
Romanov AE
Puchkova LV
Ilyechova EY
author_facet Skomorokhova EA
Sankova TP
Orlov IA
Savelev AN
Magazenkova DN
Pliss MG
Skvortsov AN
Sosnin IM
Kirilenko DA
Grishchuk IV
Sakhenberg EI
Polishchuk EV
Brunkov PN
Romanov AE
Puchkova LV
Ilyechova EY
author_sort Skomorokhova EA
title Size-Dependent Bioactivity of Silver Nanoparticles: Antibacterial Properties, Influence on Copper Status in Mice, and Whole-Body Turnover
title_short Size-Dependent Bioactivity of Silver Nanoparticles: Antibacterial Properties, Influence on Copper Status in Mice, and Whole-Body Turnover
title_full Size-Dependent Bioactivity of Silver Nanoparticles: Antibacterial Properties, Influence on Copper Status in Mice, and Whole-Body Turnover
title_fullStr Size-Dependent Bioactivity of Silver Nanoparticles: Antibacterial Properties, Influence on Copper Status in Mice, and Whole-Body Turnover
title_full_unstemmed Size-Dependent Bioactivity of Silver Nanoparticles: Antibacterial Properties, Influence on Copper Status in Mice, and Whole-Body Turnover
title_sort size-dependent bioactivity of silver nanoparticles: antibacterial properties, influence on copper status in mice, and whole-body turnover
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/aad57b2a7574403f9eeaaef2335bf8f5
work_keys_str_mv AT skomorokhovaea sizedependentbioactivityofsilvernanoparticlesantibacterialpropertiesinfluenceoncopperstatusinmiceandwholebodyturnover
AT sankovatp sizedependentbioactivityofsilvernanoparticlesantibacterialpropertiesinfluenceoncopperstatusinmiceandwholebodyturnover
AT orlovia sizedependentbioactivityofsilvernanoparticlesantibacterialpropertiesinfluenceoncopperstatusinmiceandwholebodyturnover
AT savelevan sizedependentbioactivityofsilvernanoparticlesantibacterialpropertiesinfluenceoncopperstatusinmiceandwholebodyturnover
AT magazenkovadn sizedependentbioactivityofsilvernanoparticlesantibacterialpropertiesinfluenceoncopperstatusinmiceandwholebodyturnover
AT plissmg sizedependentbioactivityofsilvernanoparticlesantibacterialpropertiesinfluenceoncopperstatusinmiceandwholebodyturnover
AT skvortsovan sizedependentbioactivityofsilvernanoparticlesantibacterialpropertiesinfluenceoncopperstatusinmiceandwholebodyturnover
AT sosninim sizedependentbioactivityofsilvernanoparticlesantibacterialpropertiesinfluenceoncopperstatusinmiceandwholebodyturnover
AT kirilenkoda sizedependentbioactivityofsilvernanoparticlesantibacterialpropertiesinfluenceoncopperstatusinmiceandwholebodyturnover
AT grishchukiv sizedependentbioactivityofsilvernanoparticlesantibacterialpropertiesinfluenceoncopperstatusinmiceandwholebodyturnover
AT sakhenbergei sizedependentbioactivityofsilvernanoparticlesantibacterialpropertiesinfluenceoncopperstatusinmiceandwholebodyturnover
AT polishchukev sizedependentbioactivityofsilvernanoparticlesantibacterialpropertiesinfluenceoncopperstatusinmiceandwholebodyturnover
AT brunkovpn sizedependentbioactivityofsilvernanoparticlesantibacterialpropertiesinfluenceoncopperstatusinmiceandwholebodyturnover
AT romanovae sizedependentbioactivityofsilvernanoparticlesantibacterialpropertiesinfluenceoncopperstatusinmiceandwholebodyturnover
AT puchkovalv sizedependentbioactivityofsilvernanoparticlesantibacterialpropertiesinfluenceoncopperstatusinmiceandwholebodyturnover
AT ilyechovaey sizedependentbioactivityofsilvernanoparticlesantibacterialpropertiesinfluenceoncopperstatusinmiceandwholebodyturnover
_version_ 1718387528312029184
spelling oai:doaj.org-article:aad57b2a7574403f9eeaaef2335bf8f52021-12-02T15:15:32ZSize-Dependent Bioactivity of Silver Nanoparticles: Antibacterial Properties, Influence on Copper Status in Mice, and Whole-Body Turnover1177-8903https://doaj.org/article/aad57b2a7574403f9eeaaef2335bf8f52020-12-01T00:00:00Zhttps://www.dovepress.com/size-dependent-bioactivity-of-silver-nanoparticles-antibacterial-prope-peer-reviewed-article-NSAhttps://doaj.org/toc/1177-8903Ekaterina A Skomorokhova,1,2 Tatiana P Sankova,3 Iurii A Orlov,1 Andrew N Savelev,3 Daria N Magazenkova,3 Mikhail G Pliss,4,5 Alexey N Skvortsov,3 Ilya M Sosnin,1 Demid A Kirilenko,1,6 Ivan V Grishchuk,3 Elena I Sakhenberg,7 Elena V Polishchuk,1,8 Pavel N Brunkov,1,6 Alexey E Romanov,1,6 Ludmila V Puchkova,1– 3 Ekaterina Yu Ilyechova1,2 1International Research Center of Functional Materials and Devices of Optoelectronics, ITMO University, St. Petersburg, Russia; 2Department of Molecular Genetics, Research Institute of Experimental Medicine, St. Petersburg, Russia; 3Higher Engineering Physics School of the Institute of Physics, Nanotechnology and Telecommunications, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia; 4Department of Experimental Physiology and Pharmacology, Almazov National Medical Research Centre, St. Petersburg, Russia; 5Laboratory of Blood Circulation Biophysics, Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia; 6Center of Nanoheterostructures Physics, Ioffe Institute, Russian Academy of Sciences, St. Petersburg, Russia; 7Laboratory of Cell Protection Mechanisms, Institute of Cytology, Russian Academy of Sciences, St. Petersburg, Russia; 8Telethon Institute of Genetics and Medicine, Pozzuoli, Naples, ItalyCorrespondence: Ekaterina Yu Ilyechova Department of Molecular GeneticsResearch Institute of Experimental Medicine, Acad. Pavlov Street, 12, St. Petersburg 197376, RussiaTel +79217605274Fax +78122322307Email ilichevaey@itmo.ruPurpose: The ability of silver nanoparticles (AgNPs) of different sizes to influence copper metabolism in mice is assessed.Materials and Methods: AgNPs with diameters of 10, 20, and 75 nm were fabricated through a chemical reduction of silver nitrate and characterized by UV/Vis spectrometry, transmission and scanning electronic microscopy, and laser diffractometry. To test their bioactivity, Escherichia coli cells, cultured A549 cells, and C57Bl/6 mice were used. The antibacterial activity of AgNPs was determined by inhibition of colony-forming ability, and cytotoxicity was tested using the MTT test (viability, %). Ceruloplasmin (Cp, the major mammalian extracellular copper-containing protein) concentration and enzymatic activity were measured using gel-assay analyses and WB, respectively. In vitro binding of AgNPs with serum proteins was monitored with UV/Vis spectroscopy. Metal concentrations were measured using atomic absorption spectrometry.Results: The smallest AgNPs displayed the largest dose- and time-dependent antibacterial activity. All nanoparticles inhibited the metabolic activity of A549 cells in accordance with dose and time, but no correlation between cytotoxicity and nanoparticle size was found. Nanosilver was not uniformly distributed through the body of mice intraperitoneally treated with low AgNP concentrations. It was predominantly accumulated in liver. There, nanosilver was included in ceruloplasmin, and Ag-ceruloplasmin with low oxidase activity level was formed. Larger nanoparticles more effectively interfered with the copper metabolism of mice. Large AgNPs quickly induced a drop of blood serum oxidase activity to practically zero, but after cancellation of AgNP treatment, the activity was rapidly restored. A major fraction of the nanosilver was excreted in the bile with Cp. Nanosilver was bound by alpha-2-macroglobulin in vitro and in vivo, but silver did not substitute for the copper atoms of Cp in vitro.Conclusion: The data showed that even at low concentrations, AgNPs influence murine copper metabolism in size-dependent manner. This property negatively correlated with the antibacterial activity of AgNPs.Keywords: silver nanoparticles, copper status, ceruloplasmin, alpha-2-macroglobulin, bile, urineSkomorokhova EASankova TPOrlov IASavelev ANMagazenkova DNPliss MGSkvortsov ANSosnin IMKirilenko DAGrishchuk IVSakhenberg EIPolishchuk EVBrunkov PNRomanov AEPuchkova LVIlyechova EYDove Medical Pressarticlesilver nanoparticlescopper statusceruloplasminalpha-2-macroglobulinbileurineMedical technologyR855-855.5Chemical technologyTP1-1185ENNanotechnology, Science and Applications, Vol Volume 13, Pp 137-157 (2020)